ArticleJournal of managed care & specialty pharmacy2020

Population-based utilization and costs associated with tyrosine kinase inhibitors for first-line treatment of chronic myelogenous leukemia among elderly patients.

Donna R Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.